Gene Symbol | Gene ID | Gene Info |
---|---|---|
Dlx5
|
ENSMUSG00000029755.9 | distal-less homeobox 5 |
Dlx4
|
ENSMUSG00000020871.7 | distal-less homeobox 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_95145956_95146107 | Dlx4 | 230 | 0.838273 | 0.41 | 1.8e-03 | Click! |
chr11_95146198_95146349 | Dlx4 | 10 | 0.951988 | 0.29 | 3.2e-02 | Click! |
chr6_6884897_6885228 | Dlx5 | 2977 | 0.173412 | 0.59 | 2.7e-06 | Click! |
chr6_6881346_6881497 | Dlx5 | 647 | 0.605405 | 0.57 | 5.1e-06 | Click! |
chr6_6880548_6880699 | Dlx5 | 1445 | 0.299572 | 0.57 | 6.0e-06 | Click! |
chr6_6881841_6882211 | Dlx5 | 42 | 0.962408 | 0.53 | 2.9e-05 | Click! |
chr6_6880785_6880936 | Dlx5 | 1208 | 0.355576 | 0.52 | 4.3e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_139885937_139886924 | 14.95 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr7_64884497_64884825 | 11.07 |
Nsmce3 |
NSE3 homolog, SMC5-SMC6 complex component |
11664 |
0.22 |
chr6_54331780_54332180 | 10.75 |
9130019P16Rik |
RIKEN cDNA 9130019P16 gene |
4639 |
0.2 |
chr9_41889978_41890642 | 10.64 |
Gm40513 |
predicted gene, 40513 |
294 |
0.89 |
chr12_34200039_34200452 | 10.50 |
Gm18025 |
predicted gene, 18025 |
90890 |
0.09 |
chr9_22826534_22827067 | 10.25 |
Gm27639 |
predicted gene, 27639 |
53965 |
0.15 |
chr12_44839950_44840386 | 10.10 |
Gm15901 |
predicted gene 15901 |
83012 |
0.1 |
chr1_105088844_105089211 | 10.04 |
Gm29012 |
predicted gene 29012 |
27427 |
0.23 |
chr2_60713863_60714355 | 9.76 |
Itgb6 |
integrin beta 6 |
8508 |
0.24 |
chr11_49128405_49128842 | 9.64 |
Olfr56 |
olfactory receptor 56 |
1521 |
0.23 |
chr4_118123073_118123998 | 9.48 |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
11347 |
0.16 |
chr18_23036938_23037296 | 9.25 |
Nol4 |
nucleolar protein 4 |
1539 |
0.55 |
chr3_135674987_135675274 | 9.16 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
5791 |
0.21 |
chr1_36577700_36577903 | 9.06 |
Fam178b |
family with sequence similarity 178, member B |
9886 |
0.09 |
chr2_173265952_173266103 | 9.03 |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
10162 |
0.18 |
chr1_67721453_67721604 | 8.67 |
Gm15669 |
predicted gene 15669 |
70953 |
0.11 |
chr8_47242449_47242654 | 8.59 |
Stox2 |
storkhead box 2 |
135 |
0.97 |
chr12_65428316_65428602 | 8.40 |
Gm26015 |
predicted gene, 26015 |
22489 |
0.22 |
chr19_60016032_60016338 | 8.27 |
Csf1r-ps |
colony stimulating factor 1 receptor (granulocyte), pseudogene |
63247 |
0.1 |
chr15_40114597_40115428 | 8.27 |
9330182O14Rik |
RIKEN cDNA 9330182O14 gene |
19353 |
0.17 |
chr3_78792451_78792970 | 8.25 |
Gm18952 |
predicted gene, 18952 |
34091 |
0.19 |
chrX_16421293_16421615 | 8.22 |
Gm14516 |
predicted gene 14516 |
41807 |
0.19 |
chr11_57837001_57837152 | 8.19 |
Hand1 |
heart and neural crest derivatives expressed 1 |
4258 |
0.18 |
chr12_4523765_4524306 | 8.18 |
Gm31938 |
predicted gene, 31938 |
78 |
0.96 |
chr4_23636552_23636896 | 8.13 |
Gm25978 |
predicted gene, 25978 |
9979 |
0.24 |
chr9_14031794_14031981 | 8.10 |
1700019J19Rik |
RIKEN cDNA 1700019J19 gene |
57733 |
0.11 |
chr16_87319565_87320052 | 8.07 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
34377 |
0.18 |
chr5_99062665_99062987 | 8.05 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
25475 |
0.2 |
chr8_22757181_22757777 | 8.05 |
Plat |
plasminogen activator, tissue |
248 |
0.91 |
chr1_78879266_78879467 | 8.04 |
Gm29187 |
predicted gene 29187 |
58108 |
0.12 |
chr18_72178944_72179106 | 8.01 |
Dcc |
deleted in colorectal carcinoma |
171992 |
0.04 |
chr18_14844486_14844862 | 8.00 |
Gm21055 |
predicted gene, 21055 |
14006 |
0.21 |
chr11_45389248_45390018 | 7.77 |
Gm12162 |
predicted gene 12162 |
31151 |
0.21 |
chr18_15544080_15544457 | 7.77 |
Aqp4 |
aquaporin 4 |
133286 |
0.05 |
chr4_139040046_139040475 | 7.68 |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6 |
34529 |
0.11 |
chr2_141913595_141913820 | 7.62 |
Fau-ps1 |
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived), pseudogene 1 |
74918 |
0.13 |
chr4_140649265_140649575 | 7.62 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
60 |
0.97 |
chr6_51580166_51580326 | 7.39 |
Snx10 |
sorting nexin 10 |
35680 |
0.15 |
chr1_78141770_78141940 | 7.38 |
Pax3 |
paired box 3 |
54983 |
0.14 |
chr17_43451316_43451509 | 7.34 |
Gm25135 |
predicted gene, 25135 |
2843 |
0.27 |
chr3_5347364_5347521 | 7.29 |
Zfhx4 |
zinc finger homeodomain 4 |
105770 |
0.07 |
chr12_102731058_102731664 | 7.28 |
Gm28373 |
predicted gene 28373 |
4028 |
0.1 |
chr12_40097338_40097496 | 7.24 |
Scin |
scinderin |
36766 |
0.13 |
chr14_121172573_121173009 | 7.19 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
70712 |
0.11 |
chr7_101441726_101441877 | 7.15 |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
8719 |
0.14 |
chr3_98990771_98991097 | 7.13 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
49678 |
0.1 |
chr2_105447731_105447893 | 7.12 |
4930527A07Rik |
RIKEN cDNA 4930527A07 gene |
28689 |
0.18 |
chr17_11927079_11927230 | 7.06 |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
81944 |
0.1 |
chr14_24997914_24998083 | 7.06 |
Gm47907 |
predicted gene, 47907 |
33099 |
0.16 |
chr2_72426764_72427187 | 7.06 |
Cdca7 |
cell division cycle associated 7 |
49184 |
0.13 |
chr4_89433459_89434002 | 7.06 |
Gm12608 |
predicted gene 12608 |
10914 |
0.19 |
chr12_26886181_26886584 | 7.06 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
51509 |
0.18 |
chr12_106839680_106840114 | 7.05 |
1700013N06Rik |
RIKEN cDNA 1700013N06 gene |
1915 |
0.41 |
chr4_110351157_110352032 | 7.01 |
Elavl4 |
ELAV like RNA binding protein 4 |
315 |
0.93 |
chr1_52470778_52471095 | 7.00 |
Nab1 |
Ngfi-A binding protein 1 |
3879 |
0.19 |
chr8_78656855_78657358 | 6.99 |
Slc10a7 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 7 |
40068 |
0.15 |
chr15_4378780_4379184 | 6.92 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
3478 |
0.36 |
chr3_55496495_55496973 | 6.92 |
Gm42607 |
predicted gene 42607 |
12946 |
0.14 |
chr3_50249984_50250135 | 6.92 |
Gm2345 |
predicted gene 2345 |
4796 |
0.3 |
chr15_95217343_95217494 | 6.92 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
55024 |
0.17 |
chr3_9137494_9137859 | 6.88 |
Gm8860 |
predicted gene 8860 |
64909 |
0.1 |
chr4_117379821_117380196 | 6.83 |
Rnf220 |
ring finger protein 220 |
4551 |
0.2 |
chr4_41727338_41727565 | 6.83 |
Arid3c |
AT rich interactive domain 3C (BRIGHT-like) |
2835 |
0.12 |
chr2_107344929_107345116 | 6.78 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
53627 |
0.17 |
chr5_119072653_119073161 | 6.78 |
1700081H04Rik |
RIKEN cDNA 1700081H04 gene |
35327 |
0.18 |
chr8_92545686_92545926 | 6.73 |
Gm45336 |
predicted gene 45336 |
80039 |
0.09 |
chr4_81333311_81333625 | 6.73 |
Mpdz |
multiple PDZ domain protein |
427 |
0.87 |
chr13_37214983_37215134 | 6.72 |
Gm30600 |
predicted gene, 30600 |
29849 |
0.15 |
chr18_58561159_58561326 | 6.71 |
Slc27a6 |
solute carrier family 27 (fatty acid transporter), member 6 |
4985 |
0.29 |
chr5_9339805_9340127 | 6.68 |
Gm15733 |
predicted gene 15733 |
13793 |
0.19 |
chr17_73477274_73477427 | 6.68 |
Gm49876 |
predicted gene, 49876 |
16901 |
0.16 |
chr8_20372500_20373383 | 6.54 |
Gm7807 |
predicted gene 7807 |
8140 |
0.18 |
chr3_7943878_7944041 | 6.51 |
1700010I02Rik |
RIKEN cDNA 1700010I02 gene |
10923 |
0.27 |
chr13_118194455_118194632 | 6.49 |
Gm9633 |
predicted gene 9633 |
147223 |
0.04 |
chr2_50103951_50104139 | 6.47 |
Lypd6 |
LY6/PLAUR domain containing 6 |
24324 |
0.26 |
chr12_8865321_8865630 | 6.46 |
9930038B18Rik |
RIKEN cDNA 9930038B18 gene |
11907 |
0.18 |
chr17_56472537_56473329 | 6.46 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr8_10006169_10006494 | 6.45 |
Tnfsf13b |
tumor necrosis factor (ligand) superfamily, member 13b |
136 |
0.95 |
chr7_35456565_35456716 | 6.37 |
Slc7a9 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 |
6804 |
0.13 |
chr5_119005858_119006127 | 6.37 |
Gm43784 |
predicted gene 43784 |
8996 |
0.23 |
chr12_29547825_29548188 | 6.37 |
Myt1l |
myelin transcription factor 1-like |
12784 |
0.23 |
chr14_66378030_66378639 | 6.35 |
Stmn4 |
stathmin-like 4 |
33953 |
0.15 |
chr10_121873065_121873455 | 6.33 |
Gm48804 |
predicted gene, 48804 |
41202 |
0.15 |
chr6_55791826_55792546 | 6.29 |
Itprid1 |
ITPR interacting domain containing 1 |
44709 |
0.18 |
chr19_41114581_41114732 | 6.24 |
Opalin |
oligodendrocytic myelin paranodal and inner loop protein |
37543 |
0.17 |
chr15_102998776_102998949 | 6.21 |
Hoxc6 |
homeobox C6 |
605 |
0.51 |
chr4_57974813_57974964 | 6.19 |
Txn1 |
thioredoxin 1 |
18477 |
0.19 |
chr7_67849230_67849427 | 6.19 |
Gm39027 |
predicted gene, 39027 |
304 |
0.87 |
chr14_12716331_12716619 | 6.18 |
Gm48266 |
predicted gene, 48266 |
54075 |
0.13 |
chr15_87349593_87349804 | 6.16 |
A930027H12Rik |
RIKEN cDNA A930027H12 gene |
106148 |
0.07 |
chr13_18457701_18457882 | 6.15 |
Pou6f2 |
POU domain, class 6, transcription factor 2 |
60105 |
0.15 |
chr3_134099578_134100106 | 6.15 |
Gm26691 |
predicted gene, 26691 |
2223 |
0.32 |
chr16_51911131_51911438 | 6.14 |
Gm29686 |
predicted gene, 29686 |
74501 |
0.12 |
chr9_31849270_31849421 | 6.14 |
Gm31497 |
predicted gene, 31497 |
56648 |
0.1 |
chr13_5548891_5549042 | 6.14 |
Gm35330 |
predicted gene, 35330 |
2066 |
0.45 |
chr11_80623114_80623380 | 6.14 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
114141 |
0.05 |
chr8_41815390_41815553 | 6.11 |
2810404M03Rik |
RIKEN cDNA 2810404M03 gene |
11796 |
0.28 |
chr7_34714918_34715250 | 6.09 |
Chst8 |
carbohydrate sulfotransferase 8 |
17634 |
0.16 |
chr6_6463850_6464144 | 6.08 |
Gm20685 |
predicted gene 20685 |
19025 |
0.19 |
chr5_29196380_29196558 | 6.08 |
Rnf32 |
ring finger protein 32 |
118 |
0.97 |
chr1_83871239_83871487 | 6.06 |
4933436I20Rik |
RIKEN cDNA 4933436I20 gene |
40208 |
0.16 |
chr2_106512677_106513062 | 6.05 |
Gm14015 |
predicted gene 14015 |
10234 |
0.26 |
chr4_71131009_71131663 | 6.05 |
Gm11228 |
predicted gene 11228 |
203 |
0.96 |
chr8_26673155_26673312 | 6.04 |
Gm32098 |
predicted gene, 32098 |
4927 |
0.2 |
chr13_15602594_15602999 | 6.02 |
Gm48343 |
predicted gene, 48343 |
47139 |
0.16 |
chr5_17574085_17574813 | 6.01 |
Sema3c |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
168 |
0.97 |
chr5_110406260_110406691 | 6.01 |
Fbrsl1 |
fibrosin-like 1 |
19379 |
0.12 |
chr2_132427639_132427949 | 5.98 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chr17_90452845_90453205 | 5.95 |
Nrxn1 |
neurexin I |
1797 |
0.34 |
chr13_8202686_8203175 | 5.92 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
8 |
0.97 |
chr8_26677560_26678005 | 5.92 |
Gm32098 |
predicted gene, 32098 |
9476 |
0.18 |
chr2_152048577_152049360 | 5.92 |
AA387200 |
expressed sequence AA387200 |
27840 |
0.11 |
chr4_31290697_31290923 | 5.90 |
Gm11922 |
predicted gene 11922 |
89662 |
0.1 |
chr7_112416059_112416210 | 5.88 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
9026 |
0.23 |
chr4_55929179_55929426 | 5.85 |
Gm12519 |
predicted gene 12519 |
64437 |
0.14 |
chr18_32980855_32981062 | 5.84 |
Gm22814 |
predicted gene, 22814 |
23808 |
0.17 |
chr2_109579120_109579313 | 5.84 |
Gm20638 |
predicted gene 20638 |
93950 |
0.07 |
chr8_8554881_8555047 | 5.82 |
Gm31463 |
predicted gene, 31463 |
21558 |
0.14 |
chr7_113122126_113122331 | 5.82 |
Gm23662 |
predicted gene, 23662 |
2530 |
0.3 |
chr3_102025229_102025483 | 5.82 |
Nhlh2 |
nescient helix loop helix 2 |
15201 |
0.17 |
chr13_53941470_53941649 | 5.82 |
Gm34557 |
predicted gene, 34557 |
6771 |
0.18 |
chr13_57061069_57061430 | 5.79 |
Gm22777 |
predicted gene, 22777 |
130301 |
0.05 |
chr4_58670580_58670950 | 5.79 |
Gm12580 |
predicted gene 12580 |
12173 |
0.22 |
chr1_6188454_6188716 | 5.77 |
Rb1cc1 |
RB1-inducible coiled-coil 1 |
17612 |
0.21 |
chr4_32432229_32432408 | 5.76 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
14883 |
0.25 |
chr14_67283363_67283593 | 5.75 |
Gm23178 |
predicted gene, 23178 |
8515 |
0.17 |
chr13_107962046_107962222 | 5.73 |
B230220B15Rik |
RIKEN cDNA B230220B15 gene |
34151 |
0.18 |
chr13_73117014_73117369 | 5.72 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
116204 |
0.06 |
chr16_44672098_44672717 | 5.72 |
Nepro |
nucleolus and neural progenitor protein |
51894 |
0.11 |
chr1_6752243_6752413 | 5.71 |
St18 |
suppression of tumorigenicity 18 |
14753 |
0.25 |
chr5_136292941_136293092 | 5.70 |
Cux1 |
cut-like homeobox 1 |
9505 |
0.15 |
chr18_81366163_81366756 | 5.68 |
Gm30288 |
predicted gene, 30288 |
87513 |
0.08 |
chr16_7528535_7528772 | 5.66 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
175683 |
0.03 |
chr8_40650752_40651179 | 5.63 |
Mtmr7 |
myotubularin related protein 7 |
16168 |
0.14 |
chr2_144170094_144170429 | 5.62 |
Gm5535 |
predicted gene 5535 |
4103 |
0.19 |
chr3_9002490_9002641 | 5.62 |
Tpd52 |
tumor protein D52 |
1872 |
0.35 |
chr11_66984489_66984815 | 5.62 |
Gm12299 |
predicted gene 12299 |
17434 |
0.13 |
chr7_78887666_78887880 | 5.60 |
Mir7-2 |
microRNA 7-2 |
504 |
0.68 |
chr3_27862930_27863950 | 5.60 |
Gm26040 |
predicted gene, 26040 |
4673 |
0.26 |
chr8_33833220_33833615 | 5.60 |
Rbpms |
RNA binding protein gene with multiple splicing |
10254 |
0.16 |
chr3_3613607_3613959 | 5.59 |
Hnf4g |
hepatocyte nuclear factor 4, gamma |
20367 |
0.22 |
chr8_18792583_18792893 | 5.55 |
Angpt2 |
angiopoietin 2 |
51176 |
0.1 |
chr12_25871193_25871842 | 5.55 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr19_14482564_14482715 | 5.54 |
Tle4 |
transducin-like enhancer of split 4 |
112900 |
0.07 |
chr1_164896751_164897129 | 5.54 |
Gm32569 |
predicted gene, 32569 |
2651 |
0.22 |
chr11_95077800_95077985 | 5.51 |
Itga3 |
integrin alpha 3 |
1091 |
0.4 |
chr3_32616403_32617072 | 5.51 |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
152 |
0.95 |
chr13_94084329_94084618 | 5.50 |
Lhfpl2 |
lipoma HMGIC fusion partner-like 2 |
962 |
0.57 |
chr12_31895564_31895725 | 5.49 |
Cog5 |
component of oligomeric golgi complex 5 |
1523 |
0.38 |
chr6_42287707_42287865 | 5.49 |
Clcn1 |
chloride channel, voltage-sensitive 1 |
920 |
0.39 |
chr19_41164805_41164972 | 5.47 |
Tll2 |
tolloid-like 2 |
41886 |
0.16 |
chr1_159686927_159687141 | 5.46 |
Gm10530 |
predicted gene 10530 |
5372 |
0.27 |
chr7_72601928_72602360 | 5.45 |
Gm37620 |
predicted gene, 37620 |
155 |
0.96 |
chr11_75948882_75949196 | 5.44 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
10610 |
0.2 |
chr16_29934677_29934979 | 5.44 |
Gm26569 |
predicted gene, 26569 |
11688 |
0.19 |
chr9_36922106_36922345 | 5.44 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
51722 |
0.1 |
chr18_79051120_79051475 | 5.44 |
Setbp1 |
SET binding protein 1 |
58094 |
0.16 |
chr9_113811983_113812374 | 5.43 |
Clasp2 |
CLIP associating protein 2 |
408 |
0.87 |
chr3_67309812_67309963 | 5.41 |
Mlf1 |
myeloid leukemia factor 1 |
64210 |
0.11 |
chr11_12559074_12559282 | 5.41 |
Cobl |
cordon-bleu WH2 repeat |
94218 |
0.08 |
chr4_134430506_134430992 | 5.41 |
1700021N21Rik |
RIKEN cDNA 1700021N21 gene |
19422 |
0.1 |
chr5_77246118_77246290 | 5.41 |
Gm19060 |
predicted gene, 19060 |
18826 |
0.12 |
chr4_117630417_117630617 | 5.39 |
Eri3 |
exoribonuclease 3 |
6821 |
0.17 |
chr3_34504632_34504783 | 5.38 |
Gm29135 |
predicted gene 29135 |
22500 |
0.16 |
chr19_6425739_6425925 | 5.37 |
Nrxn2 |
neurexin II |
2091 |
0.17 |
chr3_63137738_63138118 | 5.35 |
Gm22433 |
predicted gene, 22433 |
14289 |
0.23 |
chrX_53607803_53608436 | 5.34 |
Rtl8c |
retrotransposon Gag like 8C |
87 |
0.92 |
chr8_28299449_28299614 | 5.34 |
Gm8100 |
predicted gene 8100 |
113691 |
0.07 |
chr7_107690580_107690754 | 5.31 |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
25356 |
0.14 |
chr12_98713848_98714199 | 5.31 |
Ptpn21 |
protein tyrosine phosphatase, non-receptor type 21 |
19790 |
0.12 |
chr4_22949575_22949726 | 5.30 |
1700025O08Rik |
RIKEN cDNA 1700025O08 gene |
11215 |
0.31 |
chr12_86911376_86911690 | 5.28 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
26735 |
0.14 |
chr16_41510930_41511158 | 5.28 |
Lsamp |
limbic system-associated membrane protein |
21814 |
0.26 |
chr1_81594178_81594459 | 5.27 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr3_103945068_103945253 | 5.27 |
Rsbn1 |
rosbin, round spermatid basic protein 1 |
16542 |
0.1 |
chr17_66417463_66417664 | 5.26 |
Gm4705 |
predicted gene 4705 |
3579 |
0.21 |
chr17_45318625_45318926 | 5.25 |
Cdc5l |
cell division cycle 5-like (S. pombe) |
96909 |
0.06 |
chr1_99287936_99288087 | 5.25 |
Gm23434 |
predicted gene, 23434 |
270647 |
0.02 |
chr7_108797627_108797969 | 5.24 |
Gm45232 |
predicted gene 45232 |
2795 |
0.17 |
chr1_155605487_155606141 | 5.24 |
Acbd6 |
acyl-Coenzyme A binding domain containing 6 |
38566 |
0.17 |
chr3_55782297_55782614 | 5.24 |
Mab21l1 |
mab-21-like 1 |
55 |
0.96 |
chr16_36074881_36075032 | 5.23 |
Ccdc58 |
coiled-coil domain containing 58 |
2872 |
0.14 |
chr9_41593811_41594013 | 5.23 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
5418 |
0.12 |
chr6_40063542_40063708 | 5.22 |
Gm37673 |
predicted gene, 37673 |
35097 |
0.13 |
chr4_98598734_98598937 | 5.22 |
Gm22625 |
predicted gene, 22625 |
40970 |
0.13 |
chr10_43106136_43106524 | 5.21 |
Gm29245 |
predicted gene 29245 |
47886 |
0.11 |
chr7_125140967_125141120 | 5.21 |
Glud-ps |
glutamate dehydrogenase, pseudogene |
65692 |
0.11 |
chr10_21091162_21091366 | 5.20 |
Gm48189 |
predicted gene, 48189 |
9296 |
0.15 |
chr7_69276815_69277321 | 5.20 |
Gm44533 |
predicted gene 44533 |
17473 |
0.24 |
chr7_51339973_51340169 | 5.19 |
Gm45002 |
predicted gene 45002 |
54758 |
0.15 |
chr1_133182693_133183354 | 5.19 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
1702 |
0.35 |
chr16_90421613_90421836 | 5.18 |
Hunk |
hormonally upregulated Neu-associated kinase |
21180 |
0.17 |
chr10_111080459_111080656 | 5.17 |
Gm48851 |
predicted gene, 48851 |
22314 |
0.15 |
chr6_138708837_138709296 | 5.17 |
Igbp1b |
immunoglobulin (CD79A) binding protein 1b |
50522 |
0.16 |
chr16_42275988_42276211 | 5.17 |
Gap43 |
growth associated protein 43 |
27 |
0.98 |
chr11_94246406_94247057 | 5.17 |
Wfikkn2 |
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
726 |
0.63 |
chr9_41697271_41698297 | 5.16 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr2_74451128_74451456 | 5.15 |
Lnpk |
lunapark, ER junction formation factor |
81814 |
0.07 |
chr12_24746783_24747204 | 5.15 |
Gm48895 |
predicted gene, 48895 |
13232 |
0.11 |
chr10_109906162_109906314 | 5.15 |
Nav3 |
neuron navigator 3 |
2215 |
0.44 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.1 | 12.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.7 | 5.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.5 | 7.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
2.2 | 11.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.2 | 6.7 | GO:0060166 | olfactory pit development(GO:0060166) |
2.1 | 10.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
2.1 | 6.4 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
2.1 | 15.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.0 | 6.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.9 | 5.7 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.9 | 5.6 | GO:0031296 | B cell costimulation(GO:0031296) |
1.8 | 5.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.8 | 7.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.6 | 4.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.5 | 3.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.5 | 6.1 | GO:0060594 | mammary gland specification(GO:0060594) |
1.5 | 4.5 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
1.5 | 7.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.5 | 4.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.5 | 8.8 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.5 | 5.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.4 | 4.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.4 | 8.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.4 | 4.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.3 | 2.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.3 | 2.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.3 | 3.8 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 2.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 5.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.2 | 3.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 4.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.2 | 3.6 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.2 | 2.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.2 | 2.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.2 | 1.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.1 | 1.1 | GO:0072034 | renal vesicle induction(GO:0072034) |
1.1 | 3.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.1 | 3.4 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.1 | 4.5 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.1 | 6.7 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.1 | 12.1 | GO:0071625 | vocalization behavior(GO:0071625) |
1.1 | 2.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.1 | 3.2 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.1 | 1.1 | GO:0097491 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) facioacoustic ganglion development(GO:1903375) |
1.1 | 1.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.0 | 3.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.0 | 1.0 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
1.0 | 2.1 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
1.0 | 3.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.0 | 2.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.0 | 3.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 3.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.0 | 2.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.0 | 3.9 | GO:0060005 | vestibular reflex(GO:0060005) |
1.0 | 2.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.0 | 2.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.0 | 2.9 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.0 | 7.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 1.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.9 | 3.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 3.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.9 | 1.9 | GO:0060174 | limb bud formation(GO:0060174) |
0.9 | 1.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.9 | 7.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.9 | 2.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.9 | 0.9 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.9 | 3.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 2.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.9 | 2.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.9 | 3.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 3.4 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.8 | 8.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.8 | 3.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.8 | 2.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.8 | 2.4 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.8 | 4.0 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.8 | 4.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.8 | 4.8 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.8 | 1.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.8 | 3.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.8 | 0.8 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.8 | 3.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.8 | 3.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.8 | 4.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.8 | 3.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.8 | 0.8 | GO:1902966 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.8 | 2.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.8 | 5.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.8 | 3.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.8 | 2.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.8 | 0.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 5.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 2.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.8 | 3.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 3.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.8 | 3.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 1.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.7 | 7.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.7 | 5.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.7 | 0.7 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.7 | 3.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.7 | 8.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.7 | 2.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 0.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.7 | 1.5 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 2.9 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.7 | 3.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 1.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.7 | 2.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.7 | 20.3 | GO:0048665 | neuron fate specification(GO:0048665) |
0.7 | 2.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.7 | 2.8 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.7 | 3.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.7 | 2.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.7 | 2.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.7 | 0.7 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.7 | 1.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.7 | 2.7 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.7 | 2.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.7 | 1.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.7 | 2.6 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.7 | 5.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 1.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.6 | 1.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 4.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.6 | 1.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 2.5 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 1.9 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.6 | 1.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.6 | 1.9 | GO:0046959 | habituation(GO:0046959) |
0.6 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 1.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 3.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 1.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 2.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.6 | 3.1 | GO:0014028 | notochord formation(GO:0014028) |
0.6 | 3.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 3.6 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.6 | 0.6 | GO:0060066 | oviduct development(GO:0060066) |
0.6 | 4.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 8.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 2.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 1.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.6 | 0.6 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.6 | 0.6 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.6 | 1.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.6 | 0.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.6 | 1.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 1.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.6 | 1.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 1.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.6 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 1.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 1.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 2.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 3.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.5 | 3.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.5 | 1.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 1.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.5 | 2.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.5 | 2.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 7.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 1.0 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.5 | 2.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 1.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.5 | 3.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.5 | 1.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 2.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 6.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 1.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 4.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 1.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.5 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 4.4 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 1.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.5 | 1.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 4.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.5 | 1.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 0.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.5 | 6.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 2.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 0.9 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.5 | 0.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 0.5 | GO:0048880 | sensory system development(GO:0048880) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.5 | 1.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 1.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.5 | 0.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.5 | 1.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 1.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.5 | 2.8 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.5 | 1.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 1.4 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.5 | 3.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.5 | 1.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.5 | 1.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 1.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 1.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.4 | 1.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 0.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.4 | 1.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 0.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.4 | 1.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 2.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 1.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 0.9 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.4 | 0.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 0.4 | GO:0035993 | hypothalamus cell migration(GO:0021855) deltoid tuberosity development(GO:0035993) |
0.4 | 2.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 3.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 5.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.4 | 1.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.4 | 1.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 0.4 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.4 | 1.7 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.4 | 2.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 0.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 1.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 0.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.4 | 1.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 0.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 1.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 1.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 2.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 1.6 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 19.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 0.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.4 | 0.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 1.2 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 1.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.4 | 1.2 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 2.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.4 | 0.4 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.4 | 2.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 0.8 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.4 | 0.8 | GO:0007494 | midgut development(GO:0007494) |
0.4 | 1.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 0.8 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 1.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 0.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.4 | 1.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 0.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 1.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.4 | 1.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 0.4 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.4 | 4.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 2.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 1.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 2.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 1.9 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.4 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 2.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 4.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.4 | 2.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 2.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.4 | 1.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 1.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 0.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 1.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.4 | 1.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.4 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 25.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 2.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.4 | 1.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 1.4 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.3 | 1.4 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 1.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.3 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 0.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 3.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 1.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 0.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 1.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.0 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 5.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 0.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 1.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.6 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 0.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 1.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 0.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.3 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 4.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 0.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.3 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 1.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 0.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.3 | 0.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.3 | 1.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 1.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 2.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.9 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.3 | 0.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 1.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 1.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 0.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 4.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.3 | 0.6 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 1.4 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 1.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.6 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.3 | 0.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 0.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 2.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 2.0 | GO:0035640 | exploration behavior(GO:0035640) |
0.3 | 0.3 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 1.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 7.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.5 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.3 | 0.5 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.3 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.5 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 1.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 0.3 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.3 | 1.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 0.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.3 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.3 | 0.3 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.3 | 2.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 1.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 3.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.2 | 1.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 1.0 | GO:0060438 | trachea development(GO:0060438) |
0.2 | 1.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 1.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 1.2 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 1.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 1.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.5 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.5 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.5 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.5 | GO:0060004 | reflex(GO:0060004) |
0.2 | 0.5 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 1.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.9 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.7 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.9 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 1.8 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.2 | 1.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.2 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.4 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.2 | 0.9 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 1.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 1.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.6 | GO:0086009 | membrane repolarization(GO:0086009) |
0.2 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 1.7 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 3.4 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 1.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.6 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.2 | 1.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 0.2 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 1.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.5 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 1.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 1.6 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 1.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.2 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 | 0.4 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.2 | 0.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 1.2 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 3.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 0.4 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.9 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.2 | 1.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 4.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.2 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.2 | 0.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.5 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 2.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 5.3 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 1.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 0.5 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.2 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.2 | 1.2 | GO:0048265 | response to pain(GO:0048265) |
0.2 | 0.4 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 1.2 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 2.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.9 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.2 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 1.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 11.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 0.7 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 1.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.8 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 3.6 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.2 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.2 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.3 | GO:0021544 | subpallium development(GO:0021544) |
0.2 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 1.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.2 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.2 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.9 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 2.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.6 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.5 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.2 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 1.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.8 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.6 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.1 | 0.3 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.2 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 2.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.4 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.8 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.5 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 2.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 1.2 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 2.3 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.3 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.9 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.7 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 1.6 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.9 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.4 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.1 | 0.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 1.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.7 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.5 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 0.4 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.9 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 2.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 1.4 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.5 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.1 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.9 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 2.1 | GO:0007588 | excretion(GO:0007588) |
0.1 | 2.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.5 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.1 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.6 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.4 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.1 | 0.6 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 3.9 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.9 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.5 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.1 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 1.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.3 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.6 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 1.2 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.1 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 1.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 4.4 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.3 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.1 | 1.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.3 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.1 | 2.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.7 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.4 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.2 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 1.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.1 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 1.0 | GO:0060563 | neuroepithelial cell differentiation(GO:0060563) |
0.1 | 0.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.3 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.2 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.1 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 3.9 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.7 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.1 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 1.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 1.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.3 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.1 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 3.8 | GO:0007411 | axon guidance(GO:0007411) |
0.1 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.1 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.1 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.1 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.1 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 1.7 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.2 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.5 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.0 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.0 | 0.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.9 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.0 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.0 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.9 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 1.3 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 1.6 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.0 | GO:0043366 | beta selection(GO:0043366) |
0.0 | 0.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.0 | 0.0 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.0 | 0.0 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.2 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.0 | 0.4 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.0 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.0 | GO:0072007 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.2 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 1.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.0 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.0 | GO:0035799 | ureter maturation(GO:0035799) |
0.0 | 0.1 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.0 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.0 | 0.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.3 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.6 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.0 | 19.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.2 | 4.9 | GO:0071953 | elastic fiber(GO:0071953) |
1.1 | 2.2 | GO:0097433 | dense body(GO:0097433) |
1.0 | 15.5 | GO:0031527 | filopodium membrane(GO:0031527) |
1.0 | 3.0 | GO:0072534 | perineuronal net(GO:0072534) |
1.0 | 3.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.9 | 1.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.8 | 5.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.8 | 4.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 2.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 9.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 5.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 42.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 11.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 11.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 10.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 4.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.6 | 1.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.6 | 3.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.6 | 2.2 | GO:1990357 | terminal web(GO:1990357) |
0.6 | 5.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 2.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 1.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 2.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 1.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 11.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 1.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 1.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.5 | 1.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 5.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 0.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 1.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 1.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 2.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.3 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 3.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 3.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 9.2 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 1.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 19.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 3.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 2.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 2.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 1.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 7.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 9.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 0.5 | GO:0044393 | microspike(GO:0044393) |
0.3 | 1.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 1.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 1.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 2.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 2.7 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.2 | 2.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 23.4 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 3.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 4.9 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 3.0 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 5.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.6 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 0.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 18.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 1.5 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 2.1 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 6.1 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 29.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 4.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 5.1 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 2.6 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 2.0 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 1.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 1.7 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 1.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 3.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 1.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.0 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 5.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.7 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 5.4 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 19.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.3 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 4.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.9 | 7.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.6 | 14.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.2 | 9.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.8 | 13.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.8 | 9.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.8 | 1.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.6 | 14.5 | GO:0038191 | neuropilin binding(GO:0038191) |
1.4 | 4.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.4 | 6.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.3 | 4.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.3 | 4.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 3.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.2 | 3.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 5.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.0 | 6.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 3.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.0 | 3.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.9 | 3.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.8 | 2.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.8 | 2.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.8 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.8 | 4.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.8 | 2.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 14.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 2.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 5.1 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 5.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.7 | 4.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.7 | 2.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 3.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 3.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 13.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 2.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 2.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 1.9 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.6 | 3.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 2.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 2.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.6 | 1.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 7.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 2.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.6 | 2.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 12.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 1.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 2.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 1.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 2.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 1.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 4.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 10.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.5 | 1.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 1.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 5.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.5 | 3.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.5 | 1.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 1.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 3.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.5 | 1.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.5 | 2.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 2.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.5 | 2.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 5.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 6.7 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 6.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 2.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 1.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 2.9 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 1.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 2.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 2.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 2.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 12.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 5.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 25.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 11.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.4 | 3.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 2.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 0.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 6.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 10.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 0.7 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 1.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 2.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 1.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 2.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 1.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 0.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 4.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 1.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 0.9 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 1.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.8 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 4.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 3.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 2.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 0.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 1.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 2.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 2.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 1.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 3.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 2.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 2.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.3 | 1.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 1.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 1.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 3.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 1.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 2.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 1.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 7.2 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 2.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 6.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 3.3 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 2.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 6.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 2.4 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.2 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 2.6 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 2.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 1.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 3.0 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 2.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 2.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 2.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 2.5 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.5 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 2.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 1.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 5.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 3.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 1.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 6.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 3.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 0.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 2.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 1.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 5.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 2.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 2.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 2.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 4.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 1.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 2.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 5.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 1.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 2.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 1.2 | GO:0044606 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 3.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.4 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) acetylcholine receptor activity(GO:0015464) |
0.1 | 0.3 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 9.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.4 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 2.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 1.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 1.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.3 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.3 | GO:0034845 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 4.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 4.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 2.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 14.5 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 1.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 17.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 1.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 3.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.7 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.7 | 11.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 16.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 13.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 9.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 12.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 4.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 7.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 1.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 2.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 2.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 3.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 5.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 1.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 9.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 6.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 2.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 1.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 8.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 13.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 3.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 3.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 1.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 6.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 22.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 17.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 26.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 13.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 11.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 2.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.7 | 0.7 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.7 | 6.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.7 | 2.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 9.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 12.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 3.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 4.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 6.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 4.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 4.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 8.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 4.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 6.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 2.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 7.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 4.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 12.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 6.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 3.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 5.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 4.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 5.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 5.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 3.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 1.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 5.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 2.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 4.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 6.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 0.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 13.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 2.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 6.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 4.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 3.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 1.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 0.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 0.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 6.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 6.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 2.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.9 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 3.9 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 3.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 3.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 14.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 3.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 3.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |